This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI Cdc2
catalog :
VMA00098
quantity :
100 µl
price :
346 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00098
Description :
MOUSE ANTI Cdc2
Specificity :
Cdc2
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0051437,GO:0051403,GO:0034501,GO:0045087,GO:0051301,GO:0048011,GO:0008286,GO:0007411,GO:0008063,GO:0008353,GO:0030496,GO:0031145,GO:0034130,GO:0034134,GO:0034138,GO:0034142,GO:0000083,GO:0000186,GO:0000187,GO:0002755,GO:0002756,GO:0005829,GO:0004693,GO:0005524,GO:0005654,GO:0005876,GO:0007067,GO:0006916,GO:0007265,GO:0007173
GOTerms :
G1/S-specific transcription in mitotic cell cycle,regulation of transcription from RNA polymerase II promoter of G1/S-phase of mitotic cell cycle,regulation of transcription involved in G1/S-phase of mitotic cell cycle,activation of MAP kinase kinase activity,activation of MAP/ERK kinase kinase,activation of MAPKK activity during sporulation,GO:0007255,positive regulation of MAPKK activity,activation of MAP kinase,activation of MAPK activity during sporulation,MAPK activation,MyD88-dependent TLR signaling pathway,MyD88-dependent toll-like receptor signalling pathway,MyD88-independent TLR signaling pathway,MyD88-independent toll-like receptor signalling pathway,ATP:cyclin phosphotransferase activity,cdc2 kinase activity,CDK,CDK activity,CDK, catalytic subunit activity,cdk-activating kinase activity,Cdk-activating protein kinase activity,cyclin D-cdk6 kinase activity,cyclin D-dependent kinase activity,cyclin E kinase activity,cyclin-A associated kinase activity,cyclin-dependent kinase 6 activity,cyclin-dependent kinase activity,cyclin-dependent kinase-2 activity,cyclin-dependent kinase-4 activity,cyclin-dependent protein kinase, intrinsic catalyst activity,D-type cyclin kinase activity,GO:0016537,neuronal cdc2-like kinase activity,apoptosis inhibitor activity,EGF receptor signaling pathway,EGF receptor signalling pathway,EGFR signaling pathway,epidermal growth factor receptor signalling pathway,Ras mediated signal transduction,axon chemotaxis,axon growth cone guidance,axon pathfinding,GO:0008040,Tl signaling pathway,Tl signalling pathway,Toll signalling pathway,daf-2 receptor signaling pathway,insulin receptor signalling pathway,[RNA-polymerase]-subunit kinase activity,ATP:DNA-directed RNA polymerase phosphotransferase activity,CTD kinase activity,RNA polymerase subunit kinase activity,RNA-polymerase-subunit kinase activity,STK9,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein breakdown,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolism,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein degradation,APC-dependent proteasomal ubiquitin-dependent protein catabolic process,APC-dependent proteasomal ubiquitin-dependent protein catabolism,TLR1 signaling pathway,toll-like receptor 1 signalling pathway,TLR2 signaling pathway,toll-like receptor 2 signalling pathway,TLR3 signaling pathway,toll-like receptor 3 signalling pathway,TLR4 signaling pathway,toll-like receptor 4 signalling pathway,condensin localization to kinetochore,protein localisation to kinetochore,GO:0002226,nonspecific immune response,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,MAPK11 cascade,MAPK12 cascade,MAPK13 cascade,MAPK14 cascade,p38 cascade,p38 MAPK signaling,p38 MAPK signalling,SAPK cascade,stress-activated MAPK signaling pathway,stress-activated MAPK signalling pathway,stress-activated MAPKKK cascade,stress-activated MAPKKK signaling pathway,stress-activated MAPKKK signalling pathway,activation of ubiquitin ligase activity during mitotic cell cycle,mitotic SCF complex activator,mitotic ubiquitin ligase activator,positive regulation of ubiquitin ligase activity during mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,stimulation of ubiquitin ligase activity during mitotic cell cycle,up regulation of ubiquitin ligase activity during mitotic cell cycle,upregulation of ubiquitin ligase activity during mitotic cell cycle,up-regulation of ubiquitin ligase activity during mitotic cell cycle
UniprotAccessions :
P06493
Gene :
CDK1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=983
EntityFormats :
Purified
UNSPSC :
41116161
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.